[Anticoagulant].
Mitome
Jun
J
Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine.
Yamamoto
Hiroyasu
H
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects; D001120:Arginine / Q000031:analogs & derivatives; D001550:Benzamidines; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D015195:Drug Design; D017984:Enoxaparin; D005112:Extracorporeal Circulation; D006146:Guanidines / Q000008:administration & dosage / Q000009:adverse effects; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects; D006496:Heparinoids; D006497:Heparan Sulfate; D006801:Humans; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000009:adverse effects; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D011486:Protein C; D011994:Recombinant Proteins; D016060:Sorption Detoxification; D013449:Sulfonamides; D018180:Thrombomodulin
D000925:Anticoagulants; D000991:Antithrombins; D001120:Arginine; D001550:Benzamidines; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D017984:Enoxaparin; D006146:Guanidines; D006493:Heparin; D006495:Heparin, Low-Molecular-Weight; D006496:Heparinoids; D006497:Heparan Sulfate; D010875:Pipecolic Acids; D011480:Protease Inhibitors; D011486:Protein C; D011994:Recombinant Proteins; D013449:Sulfonamides; D018180:Thrombomodulin; C472045:ART123; C035838:danaparoid; C031942:argatroban; C032855:nafamostat